Aster Capital Management (Difc) LTD Pulse Biosciences, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 77 shares of PLSE stock, worth $1,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77Holding current value
$1,302% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLSE
# of Institutions
77Shares Held
5.41MCall Options Held
139KPut Options Held
84.2K-
Black Rock Inc. New York, NY1.15MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$16.8 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC786KShares$13.3 Million0.0% of portfolio
-
State Street Corp Boston, MA461KShares$7.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA457KShares$7.73 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $628M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...